Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07112105 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT07112105: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07112105 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07112105, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This placebo controlled study will test the effectiveness of rTMS in the treatment of SUD, and explore biomarkers that may guide patient selection for rTMS treatment and predict treatment response.
Primary Outcome
Rate of stimulant use relapse compared between active vs. sham rTMS groups
Interventions
- DEVICE Repetitive transcranial magnetic stimulation (rTMS)
- DEVICE Sham rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What is known before NCT07112105 opens enrollment
NCT07112105 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT07112105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07112105 about?
NCT07112105 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder". The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This plac...
What is the current status of trial NCT07112105?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2026-05-01. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07112105?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Sham rTMS (DEVICE).
Who is sponsoring clinical trial NCT07112105?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07112105's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI